312 related articles for article (PubMed ID: 28674973)
1. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
Saraf A; Grubb CS; Hwang ME; Tai CH; Wu CC; Jani A; Lapa ME; Andrews JIS; Vanderkelen S; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJC
J Neurooncol; 2017 Sep; 134(2):453-463. PubMed ID: 28674973
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.
Hulsbergen AFC; Lamba N; Claes A; Kavouridis VK; Lin NU; Smith TR; Verhoeff JJC; Broekman MLD
World Neurosurg; 2019 Aug; 128():e157-e164. PubMed ID: 31035019
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases.
Cagney DN; Lamba N; Montoya S; Li P; Besse L; Martin AM; Brigell RH; Catalano PJ; Brown PD; Leone JP; Tanguturi SK; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
Breast Cancer Res Treat; 2019 Jul; 176(1):171-179. PubMed ID: 30982195
[TBL] [Abstract][Full Text] [Related]
4. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy.
Leone JP; Lee AV; Brufsky AM
Cancer Med; 2015 Jul; 4(7):989-94. PubMed ID: 25756607
[TBL] [Abstract][Full Text] [Related]
7. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
Sambade MJ; Prince G; Deal AM; Trembath D; McKee M; Garrett A; Keith K; Ramirez J; Midkiff B; Blackwell K; Sammons S; Leone JP; Brufsky A; Morikawa A; Brogi E; Seidman A; Ewend M; Carey LA; Moschos SJ; Hamilton RL; Vincent B; Anders C
Breast Cancer Res Treat; 2019 Jul; 176(2):321-328. PubMed ID: 31016641
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database.
Kim YJ; Kim JS; Kim IA
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1803-1816. PubMed ID: 29971531
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
10. Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer.
Dawood S; Lei X; Litton JK; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM
Cancer; 2012 Oct; 118(19):4652-9. PubMed ID: 22359359
[TBL] [Abstract][Full Text] [Related]
11. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective analysis of clinic-pathological characteristics and prognostic factor for 137 cases of breast cancer brain metastasis].
Gao YC; Liu H; Lu S; Zhuang XR; Wang YX; Wang T; Wu YY; Chen MX
Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):30-4. PubMed ID: 23578424
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
Chen YR; Xu ZX; Jiang LX; Dong ZW; Yu PF; Zhang Z; Gu GL
World J Clin Oncol; 2023 Nov; 14(11):445-458. PubMed ID: 38059189
[TBL] [Abstract][Full Text] [Related]
14. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
[TBL] [Abstract][Full Text] [Related]
15. A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.
McKee MJ; Keith K; Deal AM; Garrett AL; Wheless AA; Green RL; Benbow JM; Dees EC; Carey LA; Ewend MG; Anders CK; Zagar TM
Oncologist; 2016 Jan; 21(1):16-20. PubMed ID: 26659221
[TBL] [Abstract][Full Text] [Related]
16. Breast-conserving therapy for triple-negative breast cancer.
Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
[TBL] [Abstract][Full Text] [Related]
17. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.
Lee JA; Kim KI; Bae JW; Jung YH; An H; Lee ES;
Breast Cancer Res Treat; 2010 Aug; 123(1):177-87. PubMed ID: 20574671
[TBL] [Abstract][Full Text] [Related]
18. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
[TBL] [Abstract][Full Text] [Related]
19. The clinical, molecular, and therapeutic implications of time from primary diagnosis to brain metastasis in lung and breast cancer patients.
Ge H; Zhu K; Sun Q; Wang H; Liu H; Ge J; Liu C; Liang P; Lv Z; Bao H
Cancer Med; 2024 Jun; 13(11):e7364. PubMed ID: 38847084
[TBL] [Abstract][Full Text] [Related]
20. New insights into HER2-low breast cancer brain metastasis: A retrospective analysis.
Xu H; Wang Y; Li L; Han Y; Wu Y; Sa Q; Xu B; Wang J
Breast; 2024 Feb; 73():103669. PubMed ID: 38176304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
